Article in Nanoscale advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 4 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
7 authors at 3 institutions in 1 country.
Hyunhong KimSchool of Energy and Chemical Engineering, Ulsan National Institute of Science and Technology Unist-gil 50 (100 Banyeon-ri), Eonyang-eup, Uljugun Ulsan Metropolitan City 689-798 Republic of Korea jnpark@unist.ac.kr.
Sunyoung WooSchool of Energy and Chemical Engineering, Ulsan National Institute of Science and Technology Unist-gil 50 (100 Banyeon-ri), Eonyang-eup, Uljugun Ulsan Metropolitan City 689-798 Republic of Korea jnpark@unist.ac.kr.
Hoesu JungPreclinical Research Center, Daegu-Gyeongbuk Medical Innovation Foundation (KMEDIhub) Daegu South Korea.
Hyo-Suk AhnDivision of Cardiology, Department of Internal Medicine, The Catholic University of Korea, Uijeongbu St. Mary's Hospital Uijeongbu Korea.
Ning ChenSchool of Energy and Chemical Engineering, Ulsan National Institute of Science and Technology Unist-gil 50 (100 Banyeon-ri), Eonyang-eup, Uljugun Ulsan Metropolitan City 689-798 Republic of Korea jnpark@unist.ac.kr.
HyungJoon ChoDepartment of Biomedical Engineering, Ulsan National Institute of Science and Technology Unist-gil 50 (100 Banyeon-ri), Eonyang-eup, Uljugun Ulsan Metropolitan City 689-798 Republic of Korea.
Jongnam ParkSchool of Energy and Chemical Engineering, Ulsan National Institute of Science and Technology Unist-gil 50 (100 Banyeon-ri), Eonyang-eup, Uljugun Ulsan Metropolitan City 689-798 Republic of Korea jnpark@unist.ac.kr.ORCID https://orcid.org/0000-0002-0954-0172
Ulsan National Institute of Science and Technology · KRDaegu-Gyeongbuk Medical Innovation Foundation · KRThe Catholic University of Korea Uijeongbu St. Mary's Hospital · KR
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
Surface engineered iron oxide nanoparticles (IONPs) with catecholic ligands have been investigated as alternative
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Amine-assisted catechol-based nanocoating on ultrasmall iron oxide nanoparticles for high-resolution · full record | OpenQuestion